Detalhe da pesquisa
1.
Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria.
Vaccine
; 41(6): 1265-1273, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642628
2.
CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
PLoS One
; 17(4): e0266691, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390102
3.
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
PLoS One
; 17(10): e0276241, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251675
4.
IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
PLoS One
; 16(8): e0256396, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415964
5.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One
; 16(9): e0256980, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495988
6.
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
PLoS One
; 15(6): e0233840, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32555601